Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS November 19, 2018 Evolus Receives Conditional FDA Acceptance of Jeuveau™ Brand Name November 5, 2018 Evolus Reports Third Quarter 2018 Financial Results November 1, 2018 Evolus to Participate in Two Upcoming Investor Conferences View all EVENTS Stifel 2018 Healthcare Conference Nov 13, 2018 at 8:00 AM EST Q3 2018 Evolus Earnings Conference Call Nov 5, 2018 at 4:30 PM EST Cantor Global Healthcare Conference Oct 1, 2018 at 8:55 AM EDT View all PRESENTATION November 2018 Investor Presentation Nov 06, 2018
